AI Article Synopsis
- * There is a lack of reliable treatments, but anti-inflammatory agents like tumor necrosis factor-alpha inhibitors can help severe cases.
- * A pediatric patient with severe hidradenitis suppurativa showed improvement when treated with a combination of high-dose ustekinumab and hyperbaric oxygen therapy.
Article Abstract
Hidradenitis suppurativa is a painful chronic inflammatory skin condition characterized by inflammatory nodules that can lead to sinus tracts and scarring. Numerous treatments have been reported, though none have reliable efficacy. Antiinflammatory agents, such as tumor necrosis factor-alpha inhibitors and interleukin inhibitors, have been used as medical therapy for refractory cases. We describe here a case of severe hidradenitis suppurativa in a pediatric patient successfully treated with a combination of high-dose ustekinumab and hyperbaric oxygen therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pde.13775 | DOI Listing |
Publication Analysis
Top Keywords
hidradenitis suppurativa
12
hyperbaric oxygen
8
oxygen therapy
8
severe hidradenitis
8
combination hyperbaric
4
therapy ustekinumab
4
ustekinumab severe
4
suppurativa hidradenitis
4
suppurativa painful
4
painful chronic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!